Cardiome

Cardiome Posts 4Q Profit

Cardiome Posts 4Q Profit

Yahoo/Zacks

Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results

Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results

Yahoo

Cardiome to pay $20 million, settle debt deal with Merck

Cardiome to pay $20 million, settle debt deal with Merck

Reuters

Merck Returns To Cardiome All Rights To Atrial Fibrillation Drug Vernakalant

Merck Returns To Cardiome All Rights To Atrial Fibrillation Drug Vernakalant

Forbes

Cardiome Announces Workforce Reduction

Cardiome Announces Workforce Reduction

Yahoo

Cardiome Pharma 4Q loss shrinks on lower costs

Cardiome Pharma 4Q loss shrinks on lower costs

Yahoo/AP

Cardiome Investors: Why Shares Crashed 50%

Cardiome Investors: Why Shares Crashed 50%

Motley Fool

Cardiome provides update on Merck's development plans for Vernakalant Oral

Cardiome provides update on Merck's development plans for Vernakalant Oral

The Fly on the Wall

Cardiome Reports Second Quarter Results

Cardiome Reports Second Quarter Results

Yahoo

Switching Partners Provides a Big Shot in the Arm

Switching Partners Provides a Big Shot in the Arm

Motley Fool